However, these alterations in immune responses do not translate to changes in vaccine efficacy, suggesting that, in the case of picornavirus vaccination against GL261-quad cassette gliomas, vector-specific CD8 T cell responses do not prevent an effective tumor antigen-specific response. Here, CD8A is linked to central nervous system cancer.